Last ¥2,438 JPY
Change Today +2.00 / 0.08%
Volume 60.8K
As of 1:00 AM 11/27/14 All times are local (Market data is delayed by at least 15 minutes).

jcr pharmaceuticals co ltd (4552) Snapshot

Open
¥2,432
Previous Close
¥2,436
Day High
¥2,485
Day Low
¥2,421
52 Week High
09/25/14 - ¥2,933
52 Week Low
12/24/13 - ¥1,549
Market Cap
79.0B
Average Volume 10 Days
48.3K
EPS TTM
¥41.51
Shares Outstanding
32.4M
EX-Date
03/27/15
P/E TM
58.7x
Dividend
¥17.00
Dividend Yield
0.76%
Current Stock Chart for JCR PHARMACEUTICALS CO LTD (4552)

Related News

No related news articles were found.

jcr pharmaceuticals co ltd (4552) Related Businessweek News

No Related Businessweek News Found

jcr pharmaceuticals co ltd (4552) Details

JCR Pharmaceuticals Co., Ltd. is engaged in the research, development, manufacture, and sale of pharmaceutical products based on recombinant DNA technologies. Its product pipeline includes Follicle stimulating hormone, which is in preparation for Phase II/III clinical trials for the treatment of infertility; Epoetin Alfa, a Phase I clinical product for the treatment of renal anemia and predeposit autologous blood; and Darbopoietin Alfa, a preclinical stage product for use in renal anemia treatment. The company’s products under preparation for clinical trials include Iduronate-2-sulfatase and Alpha-galactosidase A for the treatment of lysosomal storage disease; and under preclinical stage comprise Glucocerebrosidase for the treatment of lysosomal storage disease. It also develops Human mesenchymal stem cells, which is in Phase II/III clinical trials for the treatment of graft-versus-host disease associated with hematopoietic stem cell transplantation. JCR Pharmaceuticals Co., Ltd. was founded in 1975 and is headquartered in Ashiya, Japan.

472 Employees
Last Reported Date: 06/24/14
Founded in 1975

jcr pharmaceuticals co ltd (4552) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jcr pharmaceuticals co ltd (4552) Key Developments

JCR Pharmaceuticals Co., Ltd. to Report Q2, 2015 Results on Oct 31, 2014

JCR Pharmaceuticals Co., Ltd. announced that they will report Q2, 2015 results on Oct 31, 2014

JCR Pharmaceuticals Co., Ltd., Annual General Meeting, Jun 24, 2014

JCR Pharmaceuticals Co., Ltd., Annual General Meeting, Jun 24, 2014.

JCR Pharmaceuticals Co., Ltd. to Report Fiscal Year 2014 Results on May 09, 2014

JCR Pharmaceuticals Co., Ltd. announced that they will report fiscal year 2014 results on May 09, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4552:JP ¥2,438.00 JPY +2.00

4552 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4552.
View Industry Companies
 

Industry Analysis

4552

Industry Average

Valuation 4552 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JCR PHARMACEUTICALS CO LTD, please visit www.jcrpharm.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.